Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+3.05%)
As of: Oct 2, 2026 · 10:47 AM EDT

Rani Therapeutics Holdings (RANI) Receivables - Other (2020 - 2024)

Updated

Rani Therapeutics Holdings (RANI) posted Receivables - Other of $428,000 for Q4 2024.

Analysis

Rani Therapeutics Holdings (RANI) Receivables - Other (2020 - 2024) Analysis & Trends

  • Annual Receivables - Other shows a four-year compound annual growth rate of -29.4% (FY2020 to FY2024).
  • In prior years, Rani Therapeutics Holdings' Receivables - Other was $1.72 million in FY2020.
  • The Q4 2024 figure stands as the highest quarterly Receivables - Other since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 428,000.00
Dec 31, 2020 1.72 Mn
API Access

Rani Therapeutics Holdings Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=RANI&period=max&api_key=YOUR_API_KEY